OnCore Login

Return to Trial Database

HCRN-GI23-617

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Status

Currently Enrolling

Cancer Type(s)

Small Bowel

Study Contact

(317) 921-2050
studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-GI23-617 being conducted in.
Moffitt Cancer Center
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278